|
[1]
|
J. A. Gonzalez-Correa, et al. Effects of propofol on the leukocyte nitric oxide pathway: In vitro and ex vivo studies in surgical patients. Naunyn-Schmiedeberg’s Archives of Pharmacology, 2008, 376(5): 331-339.
|
|
[2]
|
H. K. Song, D. C. Jeong. The effect of propofol on cytotoxicity and apoptosis of lipopolysaccharide-treated mononuclear cells and lymphocytes. Anesthesia & Analgesia, 2004, 98(6): 1724- 1728.
|
|
[3]
|
Y. C. Liu, et al. Differential protection against oxidative stress and nitric oxide overproduction in cardiovascular and pulmonary systems by propofol during endotoxemia. Journal of Biomedical Science, 2009, 16: 8.
|
|
[4]
|
X. P. Dong, T. L. Xu. The actions of propofol on gamma-ami- nobutyric acid-A and glycine receptors in acutely dissociated spinal dorsal horn neurons of the rat. Anesthesia & Analgesia, 2002, 95(4): 907-914.
|
|
[5]
|
O. H. Wilder-Smith, M. Kolletzki and C. H. Wilder-Smith. Sedation with intravenous infusions of propofol or thiopentone. Effects on pain perception. Anaesthesia, 1995, 50(3): 218-222.
|
|
[6]
|
Y. C. Tsai, et al. Propofol does not reduce infarct volume in rats undergoing permanent middle cerebral artery occlusion. Acta anaesthesiologica Sinica, 1994, 32(2): 99-104.
|
|
[7]
|
C. Liang, et al. Propofol attenuates cerebral ischemia/reperfu- sion injury partially using heme oxygenase-1. Journal of Neurosurgical Anesthesiology, 2013, 25(3): 311-316.
|
|
[8]
|
J. He, et al. Propofol exerts hippocampal neuron protective effects via up-regulation of metallothionein-3. Neurological Sciences, 2013, 34(2): 165-171.
|
|
[9]
|
L. J. Velly, et al. Neuroprotective effects of propofol in a model of ischemic cortical cell cultures: Role of glutamate and its transporters. Anesthesiology, 2003, 99(2): 368-375.
|
|
[10]
|
C. Adembri, et al. Neuroprotective effects of propofol in models of cerebral ischemia: Inhibition of mitochondrial swelling as a possible mechanism. Anesthesiology, 2006, 104(1): 80-89.
|
|
[11]
|
李岩, 陈国忠, 刘韧等. 异丙酚减轻大鼠创伤性脑水肿及相关机制的研究. 医学综述, 2009, 15(9): 1410-1412.
|
|
[12]
|
M. Coburn, et al. Incidence of postoperative nausea and emetic episodes after xenon anaesthesia compared with propofol-based anaesthesia. British Journal of Anaesthesia, 2008, 100(6): 787- 791.
|
|
[13]
|
A. Borgeat, H. R. Stirnemann. Antiemetic effect of propofol. Anaesthesist, 1998, 47(11): 918-924.
|
|
[14]
|
A. Borgeat, et al., Propofol and spontaneous movements: An EEG study. Anesthesiology, 1991, 74(1): 24-27.
|
|
[15]
|
B. L. Appadu, P. G. Strange and D.G. Lambert. Does propofol interact with D2 dopamine receptors? Anesthesia & Analgesia, 1994, 79(6): 1191-1192.
|
|
[16]
|
S. A. Helmy, R. J. Al-Attiyah. The im-munomodulatory effects of prolonged intravenous infusion of propofol versus midazolam in critically ill surgical patients. Anaesthesia, 2001, 56(1): 4-8.
|
|
[17]
|
A. Kushida, T. Inada and K. Shingu. Enhancement of antitumor immunity after propofol treatment in mice. Immunopharmacology and Immunotoxicology, 2007, 29(3-4): 477-486.
|
|
[18]
|
V. Volke, et al. Inhibition of nitric oxide synthase causes anxiolytic-like behaviour in an elevated plus-maze. Neuroreport, 1995, 6(10): 1413-1416.
|
|
[19]
|
A. D. Manataki, et al. Lipid peroxidation and the use of emulsified propofol in laparoscopic surgery. Surgical Endoscopy, 2001. 15(9): 950-953.
|
|
[20]
|
P. Sanchez-Conde, et al. The comparative abilities of propofol and sevoflurane to modulate inflammation and oxidative stress in the kidney after aortic cross-clamping. Anesthesia & Analge- sia, 2008, 106(2): 371-378.
|